Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Mist and freezing fog may be stubborn to clear from Lancashire on Monday morning, but with good sunshine away from the fog - frosty
The end of 2014 looks like being cold and frosty with some freezing fog. Sunday night may also be the coldest night of the calendar year!
Freezing fog, frost and icy stretches are forecast for parts of the Granada region - here's how to navigate the roads safely